China’s State Council Announces Major Policies to Reform the Pharmaceutical Industry

Published date20 February 2017
Law FirmRopes & Gray LLP
AuthorKatherine Wang
Subject MatterChina,Regulatory Agenda,Healthcare Reform,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT